Share:
Peer-Reviewed Publication
Acad Radiol2023;30(2):183-195.February 1, 2023Journal Article

Multiparametric Quantitative Imaging Biomarkers for Phenotype Classification: A Framework for Development and Validation.

Jana G Delfino1, Gene A Pennello2, Huiman X Barnhart3, Andrew J Buckler4, Xiaofeng Wang5, Erich P Huang6, Dave L Raunig7, Alexander R Guimaraes8, Timothy J Hall9, Nandita M deSouza10, Nancy Obuchowski11
1Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD. Electronic address: Jana.Delfino@fda.hhs.gov.
2Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
3Department of Biostatistics and Bioinformatics, Duke University, Durham, NC.
4Elucid Bioimaging, Inc, Boston, MA.
5Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
6Biometric Research Program, Division of Cancer Treatment and Diagnosis - National Cancer Institute, National Institutes of Health, Bethesda, MD.
7Data Science Institute, Statistical and Quantitative Sciences, Takeda Pharmaceuticals America Inc, Lexington, MA.
8Department of Diagnostic Radiology, Oregon Health & Sciences University, Portland, OR.
9Department of Medical Physics, University of Wisconsin, Madison, WI.
10Division of Radiotherapy and Imaging, the Insitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom; European Imaging Biomarkers Alliance (EIBALL), European Society of Radiology (ESR), Vienna, Austria.
11Department of Quantitative Health Sciences, Lerner Research Institute Cleveland Clinic, Cleveland, OH.

Abstract

This manuscript is the third in a five-part series related to statistical assessment methodology for technical performance of multi-parametric quantitative imaging biomarkers (mp-QIBs). We outline approaches and statistical methodologies for developing and evaluating a phenotype classification model from a set of multiparametric QIBs. We then describe validation studies of the classifier for preci…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.